Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics of m6A-related LncRNAs in breast cancer as prognostic biomarkers and immunotherapy. | J Cancer | 2023 | 37781080 | PubTator, text mining | PubMed |
| Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis. | Int J Biol Sci | 2023 | 37781028 | PubTator, text mining | PubMed |
| Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer. | Front Med (Lausanne) | 2023 | 37780567 | PubTator, text mining | PubMed |
| PCIF1, the only methyltransferase of N6,2-O-dimethyladenosine. | Cancer Cell Int | 2023 | 37779183 | PubTator, text mining | PubMed |
| Transcription factor E4F1 as a regulator of cell life and disease progression. | Sci Adv | 2023 | 37774036 | PubTator, text mining | PubMed |
| LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation. | Cell Death Discov | 2023 | 37773181 | PubTator, text mining | PubMed |
| Role of histone lactylation interference RNA m6A modification and immune microenvironment homeostasis in pulmonary arterial hypertension. | Front Cell Dev Biol | 2023 | 37771377 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review. | Epigenetics | 2023 | 37766615 | PubTator, text mining | PubMed |
| The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas. | Brain Sci | 2023 | 37759912 | PubTator, text mining | PubMed |
| The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets. | Brain Sci | 2023 | 37759870 | PubTator, text mining | PubMed |
| A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m6A Modification to Blood Biomarkers. | Cells | 2023 | 37759495 | PubTator, text mining | PubMed |
| CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma. | J Exp Clin Cancer Res | 2023 | 37759224 | PubTator, text mining | PubMed |
| Comparative Analysis of Heart Regeneration: Searching for the Key to Heal the Heart-Part II: Molecular Mechanisms of Cardiac Regeneration. | J Cardiovasc Dev Dis | 2023 | 37754786 | PubTator, text mining | PubMed |
| Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension. | Front Immunol | 2023 | 37753070 | PubTator, text mining | PubMed |
| ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression. | iScience | 2023 | 37752950 | PubTator, text mining | PubMed |
| Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. | World J Gastrointest Oncol | 2023 | 37746645 | PubTator, text mining | PubMed |
| ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control. | Cell Rep | 2023 | 37742191 | PubTator, text mining | PubMed |
| METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC. | Commun Biol | 2023 | 37741915 | PubTator, text mining | PubMed |
| Identification of the expression patterns and potential prognostic role of m6A-RNA methylation regulators in Wilms Tumor. | BMC Med Genomics | 2023 | 37735424 | PubTator, text mining | PubMed |
| M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction. | Sci Rep | 2023 | 37735234 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=40